Its important you know that this blog post is for educational and informational purposes
To assess the utility of the model in a real world setting, we applied the model to a set of EHR data not used during model construction, and predicted efficacy at 6 months, assuming that the drug type and final dose was unknown at time point zero
Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease
Hyperandrogenism is characterized by elevated total or free testosterone levels, increased androstenedione secretion from the ovaries, or increased dehydroepiandrosterone sulfate secretion from the adrenal gland (DHEAS, an androgen marker for adrenal function)
An individualized approach with slower dose escalation and more frequent monitoring is appropriate for this population
Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination